Naseem Zojwalla
2023
In 2023, Naseem Zojwalla earned a total compensation of $1.3M as Chief Medical Officer at Olema Pharmaceuticals, a 42% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $262,000 |
|---|---|
| Option Awards | $546,000 |
| Salary | $477,000 |
| Other | $14,370 |
| Total | $1,299,370 |
Zojwalla received $546K in option awards, accounting for 42% of the total pay in 2023.
Zojwalla also received $262K in non-equity incentive plan, $477K in salary and $14.4K in other compensation.
Rankings
In 2023, Naseem Zojwalla's compensation ranked 930th out of 2,978 executives tracked by ExecPay. In other words, Zojwalla earned more than 68.8% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 930 out of 2,978 | 69th |
Division Manufacturing | 548 out of 1,637 | 67th |
Major group Chemicals And Allied Products | 372 out of 906 | 59th |
Industry group Drugs | 361 out of 869 | 59th |
Industry Pharmaceutical Preparations | 246 out of 627 | 61st |
Source: SEC filing on April 26, 2024.
Zojwalla's colleagues
We found three more compensation records of executives who worked with Naseem Zojwalla at Olema Pharmaceuticals in 2023.